WIPF1 and breast carcinoma: WIPF1 knockdown in glioblastoma and breast cancer cells expressing mtp53 greatly reduced the proliferation and growth capacity of cancer stem cell-like cells and reduced the expression of cancer stem cell-like markers (CD44, CD133 or TAZ/YAP).